Stay updated on Oral Risdiplam in Healthy Volunteers: Clinical Trial
Sign up to get notified when there's something new on the Oral Risdiplam in Healthy Volunteers: Clinical Trial page.

Latest updates to the Oral Risdiplam in Healthy Volunteers: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the completed Phase 1 risdiplam study in healthy volunteers is displayed, with its study plan, eligibility criteria, outcome measures, and record history. It replaces a 403 access-denied page.SummaryDifference52%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA notice about NIH website changes and terminology appears above the 403 error page.SummaryDifference1%

- Check32 days agoChange DetectedThe site revision in the footer changes from v3.7.1 to v3.7.2, while the study record remains behind a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This indicates the trial details are no longer accessible on the page.SummaryDifference19%

Stay in the know with updates to Oral Risdiplam in Healthy Volunteers: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Risdiplam in Healthy Volunteers: Clinical Trial page.